Baxiva
1 known investors
Baxiva is a biotechnology startup developing glycoconjugate vaccines to prevent bacterial infections with high clinical burden and antimicrobial resistance. Its lead program targets urinary tract and invasive infections caused by Escherichia coli.
Investors · 1
Frequently asked questions
- What does Baxiva do?
- Baxiva is a biotechnology startup developing glycoconjugate vaccines to prevent bacterial infections with high clinical burden and antimicrobial resistance. Its lead program targets urinary tract and invasive infections caused by Escherichia coli.
- Who are Baxiva's investors?
- Baxiva's investors include Kickfund.